ONX-0914 (PR-957) 10mM (in 1mL DMSO) | 98.11%
APEXBIO TECHNOLOGY LLC
Immunoproteasome inhibitor,potent and selective Ubiquitination/ Proteasome|Proteasome
More Information Supplier PageONX-0914 (PR-957)
Search Results
ONX-0914 (PR-957) Evaluation Sample | 98.11%
APEXBIO TECHNOLOGY LLC
Immunoproteasome inhibitor,potent and selective Ubiquitination/ Proteasome|Proteasome
More Information Supplier PageONX-0914 (PR-957)
ONX-0914 (PR-957) 5mg | 98.11%
APEXBIO TECHNOLOGY LLC
Immunoproteasome inhibitor,potent and selective Ubiquitination/ Proteasome|Proteasome
More Information Supplier PageONX-0914 (PR-957)
ONX-0914 (PR-957) 10mg | 98.11%
APEXBIO TECHNOLOGY LLC
Immunoproteasome inhibitor,potent and selective Ubiquitination/ Proteasome|Proteasome
More Information Supplier PageONX-0914 (PR-957)
ONX-0914 (PR-957) 50mg | 98.11%
APEXBIO TECHNOLOGY LLC
Immunoproteasome inhibitor,potent and selective Ubiquitination/ Proteasome|Proteasome
More Information Supplier PageONX-0914 (PR-957)
CEP-18770 5mg | 98.02%
APEXBIO TECHNOLOGY LLC
CEP-18770
CEP-18770 10mg | 98.02%
APEXBIO TECHNOLOGY LLC
CEP-18770
CEP-18770 50mg | 98.02%
APEXBIO TECHNOLOGY LLC
CEP-18770
CEP-18770 100mg | 98.02%
APEXBIO TECHNOLOGY LLC
CEP-18770
Salinosporamide A (NPI-0052, Marizomib) 100ug | 95%
APEXBIO TECHNOLOGY LLC
Salinosporamide A (NPI-0052, Marizomib)
